NKGen Biotech, Inc.
NKGN
$0.02
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 12.47% | 119.89% | -104.97% | 35.33% | -383.68% |
| Total Depreciation and Amortization | 10.33% | 10.67% | 9.03% | 7.24% | -1.96% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -0.60% | -145.64% | 299.67% | -143.39% | 2,938.98% |
| Change in Net Operating Assets | -288.50% | 67.21% | 131.38% | 953.24% | 299.15% |
| Cash from Operations | -0.20% | 14.68% | -8.48% | 17.91% | -26.95% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 11.11% | -- | 11.76% | -- | -38.46% |
| Cash from Investing | 11.11% | -- | 11.76% | 369.23% | -260.00% |
| Total Debt Issued | 7,995.00% | -78.56% | 2.93% | -73.68% | -98.91% |
| Total Debt Repaid | -194.67% | -- | -- | -- | -- |
| Issuance of Common Stock | 310,700.00% | -79.06% | -- | -- | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 92.71% | 222.72% | -21.42% | -- | -- |
| Cash from Financing | 486.41% | -68.51% | -3.38% | -27.91% | -132.78% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 99.98% | -101.22% | -93.78% | -98.73% | -29,300.00% |